Dark

INAB
IN8bio, Inc. Common Stock
stock NASDAQ

At Close

Apr 13, 2026 3:59:30 PM EDT

1.36USD-2.158%(-0.03)55,266

1.34Bid 1.38Ask 0.04Spread

Pre-market

Apr 13, 2026 8:24:30 AM EDT

1.37USD-1.482%(-0.02)227

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

13.29M

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

May 6, 2026 (23d)

Last Split

Jun 6, 20251for30reverse

INAB Stats

Avg. Vol. 10 Day

49,803

Avg. Vol. 30 Day

67,722

Employees

Market Cap

13,293,570

Shares Out.

9,847,089

On/Off Exchange

53%/47%

6 Month Beta

1.91

1 Year Beta

1.61

2 Year Beta

1.09

3 Year Beta

0.99

52 Week Low

1.17

52 Week High

5.82

SMA50

1.72

SMA200

1.99

1 Week

-4.26%

1 Month

-28.57%

3 Month

-37.79%

6 Month

-37.79%

1 Year

-71.73%

2 Year

-95.95%

5 Year

-99.55%

Profile

in8bio, inc. ("in8bio") is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta t cells. we are developing a broad portfolio of programs and are the first company to advance genetically modified gamma-delta t cells into the clinic.

INAB Stock Summary

IN8bio, Inc. Common Stock (NASDAQ:INAB) stock price today is $1.36, and today's volume is 55,266. INAB is down -2.158% today. The 30 day average volume is 67,722. INAB market cap is 13.29M with 9,847,089 shares outstanding.

.dark-mode .q9JF6H{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .q9JF6H{ color: #333333; background-color: white; border: 2px solid #333333; }INABIN8bio, Inc. Common Stockstock NASDAQ

INAB Stock Summary

INAB
IN8bio, Inc. Common Stock
stock NASDAQ